Cancer nanovaccine plus doxorubicin and immune checkpoint blockade overcomes chemoresistance and delays postsurgical recurrence.

Journal: Journal of nanobiotechnology •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Lee CM, Kwon YK, Won JE, et al. (2026). "Cancer nanovaccine plus doxorubicin and immune checkpoint blockade overcomes chemoresistance and delays postsurgical recurrence.". Journal of nanobiotechnology. https://doi.org/10.1186/s12951-026-04892-3